Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05158959
Other study ID # IRB NO.527/62
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 24, 2019
Est. completion date December 30, 2022

Study information

Verified date September 2021
Source Chulalongkorn University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This study investigates renal functional reserve in elderly.


Description:

The prevalence of CKD in elder is high as age has been a variable in eGFR equation. eGFR by calculation always declines in parallel with age. The assumption that a persistent over 3 months of eGFR less than 60 mL/min/1.73m2 define CKD with risk of progression and need refer to nephrologist may not necessary true in aging population. We study renal functional reserve in elderly population who risk of CKD progression and ESRD is the highest prevalence in human life cycle and explore whether renal functional reserve can be used as ad additional marker of CKD progression in elderly.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 30, 2022
Est. primary completion date June 30, 2022
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: - Patient age > 60 years at screening - Patient willing to participate in the study and can provide inform consent - Patient have residual kidney function = 90 ml/min/1.73m2 by CKD-EPI equation Exclusion Criteria: - Patient active smoking - Patient have Charlson comorbidity index > ..... - Patient active cancer - Patient contraindications for blood collection - Patients with a history of hypersensitivity to cimetidine or amino acid IV solution

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Thailand Kearkiat Praditpornsilpa Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Chulalongkorn University

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of renal functional reserve per 12 months (mL/min) Renal functional reserve defined as the difference between baseline creatinine clearance and creatinine clearance achieved under stimulation with amino acid infusion. 12 months
See also
  Status Clinical Trial Phase
Completed NCT03646370 - Assessing Virologic Success and Metabolic Changes in Patients Switching From a TDF to TAF Containing Antiretroviral Therapy Regimen
Withdrawn NCT05275907 - Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN) Phase 4
Completed NCT03142464 - Intravenous Fluids After Laparoscopic Cholecystectomy N/A
Completed NCT03039972 - Changes in Renal Function and Body Composition in Pulmonary Hypertension